These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 9200944
21. Costimulation and its role in organ transplantation. Bluestone JA. Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045 [Abstract] [Full Text] [Related]
22. Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig. Knoerzer DB, Karr RW, Schwartz BD, Mengle-Gaw LJ. J Clin Invest; 1995 Aug; 96(2):987-93. PubMed ID: 7543497 [Abstract] [Full Text] [Related]
23. Targeted delivery of anti-CTLA-4 antibody downregulates T cell function in vitro and in vivo. Rao S, Vasu C, Martinez O, Kaithamana S, Prabhakar BS, Holterman MJ. Clin Immunol; 2001 Nov; 101(2):136-45. PubMed ID: 11683572 [Abstract] [Full Text] [Related]
24. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. Matsui T, Kurokawa M, Kobata T, Oki S, Azuma M, Tohma S, Inoue T, Yamamoto K, Nishioka K, Kato T. J Immunol; 1999 Apr 01; 162(7):4328-35. PubMed ID: 10201965 [Abstract] [Full Text] [Related]
25. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation. Saverino D, Brizzolara R, Simone R, Chiappori A, Milintenda-Floriani F, Pesce G, Bagnasco M. Clin Immunol; 2007 May 01; 123(2):190-8. PubMed ID: 17321799 [Abstract] [Full Text] [Related]
26. NK cell triggering by the human costimulatory molecules CD80 and CD86. Wilson JL, Charo J, Martín-Fontecha A, Dellabona P, Casorati G, Chambers BJ, Kiessling R, Bejarano MT, Ljunggren HG. J Immunol; 1999 Oct 15; 163(8):4207-12. PubMed ID: 10510357 [Abstract] [Full Text] [Related]
27. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. Larché M, Till SJ, Haselden BM, North J, Barkans J, Corrigan CJ, Kay AB, Robinson DS. J Immunol; 1998 Dec 01; 161(11):6375-82. PubMed ID: 9834128 [Abstract] [Full Text] [Related]
28. Is CTLA-4 a master switch for peripheral T cell tolerance? Bluestone JA. J Immunol; 1997 Mar 01; 158(5):1989-93. PubMed ID: 9036940 [Abstract] [Full Text] [Related]
29. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). Morton PA, Fu XT, Stewart JA, Giacoletto KS, White SL, Leysath CE, Evans RJ, Shieh JJ, Karr RW. J Immunol; 1996 Feb 01; 156(3):1047-54. PubMed ID: 8557978 [Abstract] [Full Text] [Related]
30. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. Freeman GJ, Lombard DB, Gimmi CD, Brod SA, Lee K, Laning JC, Hafler DA, Dorf ME, Gray GS, Reiser H. J Immunol; 1992 Dec 15; 149(12):3795-801. PubMed ID: 1281186 [Abstract] [Full Text] [Related]
31. [Regulation of T-cell activation by CD28 and CTLA-4]. Nagel T, Kalden JR, Manger B. Med Klin (Munich); 1998 Oct 15; 93(10):592-7. PubMed ID: 9849050 [Abstract] [Full Text] [Related]
32. Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80. Boulougouris G, McLeod JD, Patel YI, Ellwood CN, Walker LS, Sansom DM. J Immunol; 1998 Oct 15; 161(8):3919-24. PubMed ID: 9780158 [Abstract] [Full Text] [Related]
33. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules. Mauri D, Wyss-Coray T, Gallati H, Pichler WJ. J Immunol; 1995 Jul 01; 155(1):118-27. PubMed ID: 7541409 [Abstract] [Full Text] [Related]
34. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. Linsley PS, Bradshaw J, Urnes M, Grosmaire L, Ledbetter JA. J Immunol; 1993 Apr 15; 150(8 Pt 1):3161-9. PubMed ID: 7682233 [Abstract] [Full Text] [Related]
35. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro. Chai JG, Vendetti S, Bartok I, Schoendorf D, Takacs K, Elliott J, Lechler R, Dyson J. J Immunol; 1999 Aug 01; 163(3):1298-305. PubMed ID: 10415027 [Abstract] [Full Text] [Related]
36. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M. J Immunol; 1995 Jan 01; 154(1):97-105. PubMed ID: 7527824 [Abstract] [Full Text] [Related]
37. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4. Horspool JH, Perrin PJ, Woodcock JB, Cox JH, King CL, June CH, Harlan DM, St Louis DC, Lee KP. J Immunol; 1998 Mar 15; 160(6):2706-14. PubMed ID: 9510170 [Abstract] [Full Text] [Related]
38. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. Perrin PJ, Scott D, Quigley L, Albert PS, Feder O, Gray GS, Abe R, June CH, Racke MK. J Immunol; 1995 Feb 01; 154(3):1481-90. PubMed ID: 7529805 [Abstract] [Full Text] [Related]
39. The CD28 costimulatory pathway. Leung HT, Linsley PS. Ther Immunol; 1994 Aug 01; 1(4):217-28. PubMed ID: 7584497 [No Abstract] [Full Text] [Related]
40. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. McLellan AD, Sorg RV, Williams LA, Hart DN. Eur J Immunol; 1996 Jun 01; 26(6):1204-10. PubMed ID: 8647193 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]